Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women - Full Text View

Purpose

The goal of this research study is to measure what percentage of women who suspect they have symptoms of ADHD will go on to be diagnosed with ADHD using accepted practice standards. The study will also evaluate the influence education on the genetics of ADHD has on a woman in her deciding to receive behavioral health treatment for ADHD.

Condition	Intervention
Attention Deficit Hyperactivity Disorder	Behavioral: Education

Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Prospective
Official Title:	Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women

Resource links provided by NLM:

MedlinePlus related topics: Attention Deficit Hyperactivity Disorder

U.S. FDA Resources

Further study details as provided by Avera McKennan Hospital & University Health Center:

Primary Outcome Measures:

To determine if offering relative risk genotyping for ADHD, and educating around the genetic and environmental contributions to ADHD, may lead to greater health care acceptance in women who struggle with ADHD. [ Time Frame: 24 hours ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

To determine if women who think they have ADHD actually have ADHD. [ Time Frame: 24 hours ] [ Designated as safety issue: No ]

Biospecimen Retention: Samples With DNA

saliva

Enrollment:	60
Study Start Date:	March 2009
Study Completion Date:	January 2011
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
ADHD Women with symptoms of ADHD. Women who either think they may have ADHD or have been previously diagnosed with ADHD but have not been treated for it.	Behavioral: Education Education on the genetics of ADHD and treatment options for ADHD Other Names: Attention Deficit Hyperactivity Disorder Hyperactivity Disorder Attention Deficit Disorder Mental Health

Detailed Description:

Attention Deficit Hyperactivity Disorder (ADHD) affects approximately 10-12% of school-aged children in the United States, making it one of the most common psychiatric disorders in children. It is characterized as inattention and hyperactivity-impulsivity, which has persisted for at least 6 months to a degree that is maladaptive and inconsistent with developmental level (DSM-IV-TR). ADHD is a non-fluctuating illness unlike many other psychiatric co-morbid conditions.

Eligibility

Ages Eligible for Study:	18 Years to 59 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Women in and around the Sioux Falls area.

Criteria

Inclusion Criteria:

Subjects must be females, 18 through 59 years of age
Subjects must think they have ADHD or have been previously diagnosed with ADHD but may not have received any treatment for ADHD
Subjects must be able to participate in the informed consent process and give their written consent to participate in the study

Exclusion Criteria:

Subjects who have been treated (at any time) for ADHD will be excluded from the study
Potential subjects consuming greater than 21 units of alcohol (1 unit=12.0 ounces beer, 1.5 ounces hard liquor or 5.0 ounces wine) a week will be excluded from the study
Potential subjects currently experiencing suicidal ideation or who have been hospitalized within the past six months for suicidal ideation will be excluded from the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01272726

Locations

United States, South Dakota
Avera Research Institute
Sioux Falls, South Dakota, United States, 57105

Sponsors and Collaborators

Avera McKennan Hospital & University Health Center

Investigators

Principal Investigator:	Timothy Soundy, MD	Avera McKennan Hospital & University Health Center
Principal Investigator:	Kent Andre, MD	Avera McKennan Hospital & University Health Center
Principal Investigator:	Nicole Christensen, MD	Avera McKennan Hospital & University Health Center
Study Chair:	Gareth Davies, PhD	Avera Institute of Human Behavioral Genetics

More Information

Publications:

Murphy KR, Adler LA. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiatry. 2004;65 Suppl 3:12-7. Review.

Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry. 2000 Jul;5(4):405-9.

Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1990 Jul;29(4):526-33.

Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, Ablon S, Warburton R, Reed E. Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatry. 1995 Jun;52(6):464-70.

Faraone SV, Doyle AE. The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2001 Apr;10(2):299-316, viii-ix. Review.

Smalley SL, McGough JJ, Del'Homme M, NewDelman J, Gordon E, Kim T, Liu A, McCracken JT. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000 Sep;39(9):1135-43.

Responsible Party:	Tammy Jung, Regulatory Specialist, Avera McKennan Hospital & University Health Center
ClinicalTrials.gov Identifier:	NCT01272726 History of Changes
Other Study ID Numbers:	ARI-1260-ADHD
Study First Received:	January 6, 2011
Last Updated:	May 31, 2012
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:

Attention Deficit Disorder with Hyperactivity
Hyperkinesis
Attention Deficit and Disruptive Behavior Disorders
Mental Disorders Diagnosed in Childhood
Mental Disorders

Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 19, 2013